Starzer, Angelika M.
Steindl, Ariane
Mair, Maximilian J. http://orcid.org/0000-0002-6537-3874
Deischinger, Carola
Simonovska, Anika
Widhalm, Georg
Gatterbauer, Brigitte
Dieckmann, Karin
Heller, Gerwin http://orcid.org/0000-0001-8742-5631
Preusser, Matthias
Berghoff, Anna S. http://orcid.org/0000-0001-9379-6797
Funding for this research was provided by:
Medizinische Universität Wien
Margaretha Hehberger Stiftung, Address: Thomas-Klestil-Platz 8 1030 Wien, Austria
Article History
Received: 6 July 2020
Revised: 7 December 2020
Accepted: 17 December 2020
First Online: 21 January 2021
Change Date: 10 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-022-01722-9
Ethics approval and consent to participate
: This study was approved by the ethics committee of the Medical University of Vienna (Vote EK 078/2004). Due to the retrospective design of the study the ethics board waived the informed consent of individual patients. This study was performed in accordance with the Declaration of Helsinki.
: The data supporting the results in this manuscript is saved at a server of the Medical University of Vienna.
: A.M.S. has received travel support from PharmaMar. A.S.B. has research support from Daiichi Sankyo and Roche, honoraria for lectures, consultation or advisory board participation from Roche, Bristol-Meyers Squibb, Merck, Daiichi Sankyo as well as travel support from Roche, Amgen, Daiichi Sankyo and AbbVie. M.P. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen. The following for-profit companies have supported clinical trials and contracted research conducted by M.P. with payments made to his institution: Böhringer-Ingelheim, Bristol-Myers Squibb, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie. G.H. has received research support from Bristol-Meyers Squibb and Merck. All other authors report no conflicts of interest concerning this specific publication.
: The study costs were supported by a grant from the Margaretha Hehberger-Stiftung assigned to A.S.B. (Project 18085; title: Impact of local and systemic treatments on the inflammatory microenvironment composition in brain metastases). The funding source supported this study by partly financing a Ph.D. student.